Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study
Open Access
- 23 February 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 119 (8), 1872-1881
- https://doi.org/10.1182/blood-2011-10-382861
Abstract
Gene expression profiling was performed on 97 cases of infant ALL from Children's Oncology Group Trial P9407. Statistical modeling of an outcome predictor revealed 3 genes highly predictive of event-free survival (EFS), beyond age and MLL status: FLT3, IRX2, and TACC2. Low FLT3 expression was found in a group of infants with excellent outcome (n = 11; 5-year EFS of 100%), whereas differential expression of IRX2 and TACC2 partitioned the remaining infants into 2 groups with significantly different survivals (5-year EFS of 16% vs 64%; P < .001). When infants with MLL-AFF1 were analyzed separately, a 7-gene classifier was developed that split them into 2 distinct groups with significantly different outcomes (5-year EFS of 20% vs 65%; P < .001). In this classifier, elevated expression of NEGR1 was associated with better EFS, whereas IRX2, EPS8, and TPD52 expression were correlated with worse outcome. This classifier also predicted EFS in an independent infant ALL cohort from the Interfant-99 trial. When evaluating expression profiles as a continuous variable relative to patient age, we further identified striking differences in profiles in infants less than or equal to 90 days of age and those more than 90 days of age. These age-related patterns suggest different mechanisms of leukemogenesis and may underlie the differential outcomes historically seen in these age groups.Keywords
This publication has 45 references indexed in Scilit:
- Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patientsLeukemia, 2010
- Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesisNature Reviews Cancer, 2010
- Gene expression profiling–based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infantsBlood, 2010
- Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic optionsBlood, 2009
- DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4Leukemia, 2009
- H3K79 Methylation Profiles Define Murine and Human MLL-AF4 LeukemiasCancer Cell, 2008
- MLL translocations, histone modifications and leukaemia stem-cell developmentNature Reviews Cancer, 2007
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialThe Lancet, 2007
- Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology GroupBlood, 2006
- Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spotsProceedings of the National Academy of Sciences of the United States of America, 1997